3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
25
Breast Neoplasms
21
Glioblastoma
19
Carcinoma, Non-Small-Cell Lung
17
Sarcoma
11
Squamous Cell Carcinoma of Head and Neck
10
Lung Neoplasms
10
Rectal Neoplasms
8
Neoplasms
8
Hodgkin Disease
8
Head and Neck Neoplasms
8
Brain Neoplasms
8
Oropharyngeal Neoplasms
7
Glioma
7
Esophageal Squamous Cell Carcinoma
7
Esophageal Neoplasms
7
Uterine Cervical Neoplasms
6
Pancreatic Neoplasms
6
Astrocytoma
6
Triple Negative Breast Neoplasms
5
Lymphoma
5
Colorectal Neoplasms
5
Carcinoma, Squamous Cell
5
Neoplasm Metastasis
4
Melanoma
4
Medulloblastoma
4
Histiocytoma, Malignant Fibrous
4
Small Cell Lung Carcinoma
3
Rhabdomyosarcoma
3
Recurrence
3
Interventions
fludarabine phosphate
4
Cyclophosphamide
4
blinatumomab
3
Rituximab
3
Lenalidomide
2
Immunotherapy, Adoptive
2
venetoclax
1
trastuzumab deruxtecan
1
tisagenlecleucel
1
pembrolizumab
1
obinutuzumab
1
niraparib
1
nilotinib
1
isatuximab
1
acalabrutinib
1
Zymosan
1
Whole-Body Irradiation
1
Trastuzumab
1
Sodium Chloride
1
Sirolimus
1
Radiotherapy
1
Pentostatin
1
NKTR-255
1
Mycophenolic Acid
1
Melphalan
1
Magnetic Resonance Imaging
1
Immunotherapy
1
Imatinib Mesylate
1
Histamine Antagonists
1
Exercise Test
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Neoplasm, Residual
×
Radiotherapy
×
Clear all
NCT03945721
2025-09-29
UNITY
Massachusetts General Hospital
Phase 1
Active not recruiting
21 enrolled